EP1039801A4 - 207 proteines humaines secretees - Google Patents

207 proteines humaines secretees

Info

Publication number
EP1039801A4
EP1039801A4 EP98926237A EP98926237A EP1039801A4 EP 1039801 A4 EP1039801 A4 EP 1039801A4 EP 98926237 A EP98926237 A EP 98926237A EP 98926237 A EP98926237 A EP 98926237A EP 1039801 A4 EP1039801 A4 EP 1039801A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98926237A
Other languages
German (de)
English (en)
Other versions
EP1039801A1 (fr
Inventor
Paul Young
John Greene
Ann M Ferrie
Steven Ruben
Craig Rosen
Jing-Shan Hu
Henrik Olsen
Reinhard Ebner
Laurie A Brewer
Paul A Moore
Yanggu E Shi
Charles Florence
Kimberly Florence
David Lafleur
Jian Ni
Ping Fan
Ying-Fei Wei
Carrie Fischer
Daniel Soppet
Yi Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to EP04001119A priority Critical patent/EP1428833A3/fr
Publication of EP1039801A1 publication Critical patent/EP1039801A1/fr
Publication of EP1039801A4 publication Critical patent/EP1039801A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP98926237A 1997-06-06 1998-06-04 207 proteines humaines secretees Withdrawn EP1039801A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04001119A EP1428833A3 (fr) 1997-06-06 1998-06-04 207 protéines humaines sécrétées

Applications Claiming Priority (147)

Application Number Priority Date Filing Date Title
US4887897P 1997-06-06 1997-06-06
US4891697P 1997-06-06 1997-06-06
US4896297P 1997-06-06 1997-06-06
US4889797P 1997-06-06 1997-06-06
US4897497P 1997-06-06 1997-06-06
US4887597P 1997-06-06 1997-06-06
US4888497P 1997-06-06 1997-06-06
US4896397P 1997-06-06 1997-06-06
US4889297P 1997-06-06 1997-06-06
US4889897P 1997-06-06 1997-06-06
US4887697P 1997-06-06 1997-06-06
US4937397P 1997-06-06 1997-06-06
US4890097P 1997-06-06 1997-06-06
US4888297P 1997-06-06 1997-06-06
US4889397P 1997-06-06 1997-06-06
US4889697P 1997-06-06 1997-06-06
US4888097P 1997-06-06 1997-06-06
US4902097P 1997-06-06 1997-06-06
US4888597P 1997-06-06 1997-06-06
US4889497P 1997-06-06 1997-06-06
US4894997P 1997-06-06 1997-06-06
US4889997P 1997-06-06 1997-06-06
US4891797P 1997-06-06 1997-06-06
US4897297P 1997-06-06 1997-06-06
US4901997P 1997-06-06 1997-06-06
US4890197P 1997-06-06 1997-06-06
US4896497P 1997-06-06 1997-06-06
US4937597P 1997-06-06 1997-06-06
US4891597P 1997-06-06 1997-06-06
US4889597P 1997-06-06 1997-06-06
US4888397P 1997-06-06 1997-06-06
US4888197P 1997-06-06 1997-06-06
US4897097P 1997-06-06 1997-06-06
US4937497P 1997-06-06 1997-06-06
US4887797P 1997-06-06 1997-06-06
US4897197P 1997-06-06 1997-06-06
US48877P 1997-06-06
US49019P 1997-06-06
US48894P 1997-06-06
US48884P 1997-06-06
US48915P 1997-06-06
US48970P 1997-06-06
US48898P 1997-06-06
US48895P 1997-06-06
US48883P 1997-06-06
US48897P 1997-06-06
US48876P 1997-06-06
US48916P 1997-06-06
US48949P 1997-06-06
US48875P 1997-06-06
US48896P 1997-06-06
US48974P 1997-06-06
US49375P 1997-06-06
US48917P 1997-06-06
US49374P 1997-06-06
US48881P 1997-06-06
US48964P 1997-06-06
US48962P 1997-06-06
US48899P 1997-06-06
US49373P 1997-06-06
US48900P 1997-06-06
US48901P 1997-06-06
US48892P 1997-06-06
US48880P 1997-06-06
US48885P 1997-06-06
US48878P 1997-06-06
US48971P 1997-06-06
US49020P 1997-06-06
US48972P 1997-06-06
US48882P 1997-06-06
US48963P 1997-06-06
US48893P 1997-06-06
US57761P 1997-08-22
US57650P 1997-08-22
US5764297P 1997-09-05 1997-09-05
US5776597P 1997-09-05 1997-09-05
US5764597P 1997-09-05 1997-09-05
US5777097P 1997-09-05 1997-09-05
US5766297P 1997-09-05 1997-09-05
US5777697P 1997-09-05 1997-09-05
US5763497P 1997-09-05 1997-09-05
US5766197P 1997-09-05 1997-09-05
US5764497P 1997-09-05 1997-09-05
US5777797P 1997-09-05 1997-09-05
US5762897P 1997-09-05 1997-09-05
US5764997P 1997-09-05 1997-09-05
US5766797P 1997-09-05 1997-09-05
US5762797P 1997-09-05 1997-09-05
US5765097P 1997-09-05 1997-09-05
US5777597P 1997-09-05 1997-09-05
US5777897P 1997-09-05 1997-09-05
US5777497P 1997-09-05 1997-09-05
US5776297P 1997-09-05 1997-09-05
US5765497P 1997-09-05 1997-09-05
US5764897P 1997-09-05 1997-09-05
US5764397P 1997-09-05 1997-09-05
US5758497P 1997-09-05 1997-09-05
US5764697P 1997-09-05 1997-09-05
US5763597P 1997-09-05 1997-09-05
US5762997P 1997-09-05 1997-09-05
US5777197P 1997-09-05 1997-09-05
US5776197P 1997-09-05 1997-09-05
US5764797P 1997-09-05 1997-09-05
US5765197P 1997-09-05 1997-09-05
US5776497P 1997-09-05 1997-09-05
US5776997P 1997-09-05 1997-09-05
US5776397P 1997-09-05 1997-09-05
US5766897P 1997-09-05 1997-09-05
US5776097P 1997-09-05 1997-09-05
US5766697P 1997-09-05 1997-09-05
US57651P 1997-09-05
US57765P 1997-09-05
US57647P 1997-09-05
US57627P 1997-09-05
US57777P 1997-09-05
US57635P 1997-09-05
US57775P 1997-09-05
US57661P 1997-09-05
US57776P 1997-09-05
US57644P 1997-09-05
US57634P 1997-09-05
US57771P 1997-09-05
US57762P 1997-09-05
US57643P 1997-09-05
US57763P 1997-09-05
US57668P 1997-09-05
US57662P 1997-09-05
US57628P 1997-09-05
US57764P 1997-09-05
US57760P 1997-09-05
US57646P 1997-09-05
US57774P 1997-09-05
US57645P 1997-09-05
US57769P 1997-09-05
US57629P 1997-09-05
US57648P 1997-09-05
US57649P 1997-09-05
US57654P 1997-09-05
US57667P 1997-09-05
US57642P 1997-09-05
US57666P 1997-09-05
US57584P 1997-09-05
US57778P 1997-09-05
US57770P 1997-09-05
US7092397P 1997-12-18 1997-12-18
US70923P 1997-12-18
PCT/US1998/011422 WO1998054963A2 (fr) 1997-06-06 1998-06-04 207 proteines secretees humaines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP04001119A Division EP1428833A3 (fr) 1997-06-06 1998-06-04 207 protéines humaines sécrétées

Publications (2)

Publication Number Publication Date
EP1039801A1 EP1039801A1 (fr) 2000-10-04
EP1039801A4 true EP1039801A4 (fr) 2003-03-26

Family

ID=27587074

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98926237A Withdrawn EP1039801A4 (fr) 1997-06-06 1998-06-04 207 proteines humaines secretees

Country Status (3)

Country Link
EP (1) EP1039801A4 (fr)
CA (1) CA2291260A1 (fr)
WO (1) WO1998054963A2 (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062891A2 (fr) * 2000-02-24 2001-08-30 Human Genome Sciences, Inc. 207 proteines humaines secretees
WO1999043693A1 (fr) * 1998-02-26 1999-09-02 Human Genome Sciences, Inc. Proteines secretees par l'homme
CA2285447A1 (fr) * 1997-03-28 1998-10-08 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
CA2298451A1 (fr) * 1997-08-06 1999-02-18 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
US7378507B2 (en) * 1997-09-18 2008-05-27 Genentech, Inc. PRO217 polypeptides
US6075136A (en) * 1998-02-17 2000-06-13 Incyte Pharmaceuticals, Inc. Prostate-associated serine protease
EP0939124A3 (fr) * 1998-02-24 2001-03-21 Smithkline Beecham Plc Séquences de la MBGP1
CA2322711A1 (fr) * 1998-02-27 1999-09-02 Sagami Chemical Research Center Proteines humaines possedant des domaines transmembranaires et adn codant ces proteines
AU3010199A (en) * 1998-03-18 1999-10-11 Icos Corporation Human leupaxin polypeptide and dna encoding it, their uses
GB9807722D0 (en) * 1998-04-08 1998-06-10 Smithkline Beecham Plc Novel compounds
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor
IL140938A0 (en) 1998-08-07 2002-02-10 Immunex Corp Molecules designated b7l-1
US6528297B1 (en) * 1998-08-31 2003-03-04 Institute Of Genetics Fudan University Human lysozyme gene, its encoded polypeptide and the method for preparing them
AU2003204358B2 (en) * 1998-09-01 2006-03-30 Genentech, Inc. Further pro polypeptides and sequences thereof
JP2005502301A (ja) * 1998-09-18 2005-01-27 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒトｉｓｒｅ結合タンパク質
JP2002525117A (ja) * 1998-09-30 2002-08-13 ミレニアム・フアーマシユーチカルズ・インコーポレーテツド Ｓｌｇｐタンパク質及び核酸分子並びにそれらの使用
US7414112B2 (en) 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US6020164A (en) * 1998-10-21 2000-02-01 Incyte Pharmaceuticals, Inc. Human RNA binding proteins
EP1132473A4 (fr) 1998-11-20 2002-06-12 Fuso Pharmaceutical Ind Nouvelle serine protease bssp6
CA2356987A1 (fr) * 1998-12-23 2000-06-29 Corixa Corporation Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
GB9828704D0 (en) 1998-12-24 1999-02-17 Nippon Glaxo Limited Proteins
US6958361B2 (en) 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6590076B1 (en) 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586572B2 (en) 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
CA2361293A1 (fr) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 proteines humaines secretees
JP2002538811A (ja) * 1999-03-12 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
WO2000077026A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 49 proteines secretees humaines
WO2000061596A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 50 proteines humaines secretees
JP2002538841A (ja) * 1999-03-18 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２７個のヒト分泌タンパク質
JP2002539776A (ja) * 1999-03-23 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
JP2003501008A (ja) * 1999-03-26 2003-01-14 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
CA2370039A1 (fr) 1999-04-09 2000-10-19 Shionogi & Co., Ltd. Gene associe a l'apoptose
WO2000061755A2 (fr) * 1999-04-09 2000-10-19 Chiron Corporation Proteines humaines secretees
WO2000063382A1 (fr) * 1999-04-15 2000-10-26 Osiris Therapeutics, Inc. Genes et produits d'expression provenant de cellules hematopoietiques
CA2371702A1 (fr) * 1999-04-30 2000-11-09 Toshio Miyata Proteine meg-3
WO2000070028A1 (fr) * 1999-05-13 2000-11-23 Johnson & Johnson Research Pty. Limited Enzyme sphingosine kinase
AU4778600A (en) * 1999-05-20 2000-12-12 Takeda Chemical Industries Ltd. Novel polypeptide
CA2383828A1 (fr) * 1999-06-07 2000-12-14 Human Genome Sciences, Inc. 26 proteines humaines secretees
CA2382743A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 48 proteines secretees humaines
CA2382748A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 50 proteines humaines secretees
EP1192278A4 (fr) * 1999-06-11 2003-05-28 Human Genome Sciences Inc 48 proteines secretees humaines
AU6092700A (en) * 1999-07-14 2001-02-05 Incyte Genomics, Inc. Electron transfer proteins
WO2001009317A1 (fr) * 1999-07-29 2001-02-08 Helix Research Institute Gene associe au cancer de l'estomac
WO2001021794A2 (fr) * 1999-09-20 2001-03-29 Ludwig Institute For Cancer Research Polypeptides associant smad
US6673570B1 (en) * 1999-09-20 2004-01-06 Ludwig Institute For Cancer Research Smad associating polypeptides
JP2003517297A (ja) * 1999-09-23 2003-05-27 ライジェル・ファーマシューティカルズ・インコーポレイテッド チェックポイント遺伝子関連細胞周期タンパク質、組成物および使用法
AU1020201A (en) * 1999-10-28 2001-05-08 Warner-Lambert Company Human sphingosine kinase gene
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
ATE424457T1 (de) 2000-01-13 2009-03-15 Genentech Inc Menschliche stra6 polypeptide
AU2001238283C1 (en) * 2000-02-14 2006-02-02 Curagen Corporation Sphingosine kinases
US20020098163A1 (en) * 2000-07-24 2002-07-25 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR21 and TR22
AU2002223568A1 (en) * 2000-09-27 2002-04-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Identification of neuroblastoma tumor suppressor genes
US6630325B1 (en) * 2000-10-19 2003-10-07 Maine Medical Center Research Institute Compositions, methods and kits relating to remodel
WO2003000729A2 (fr) * 2001-06-20 2003-01-03 Genentech, Inc. Nouveau polypeptide secrete et methodes de traitement des troubles osseux
WO2003025135A2 (fr) * 2001-09-14 2003-03-27 Gene Logic, Inc. Genes associes a des tumeurs malignes
EP2305710A3 (fr) 2002-06-03 2013-05-29 Genentech, Inc. Bibliothèques de phages et anticorps synthétiques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017925A1 (fr) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designee par lerk-7
WO1997004097A2 (fr) * 1995-07-19 1997-02-06 Genetics Institute, Inc. Proteines humaines ctla-8 et utilisation de proteines apparentees aux proteines ctla-8

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017925A1 (fr) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designee par lerk-7
WO1997004097A2 (fr) * 1995-07-19 1997-02-06 Genetics Institute, Inc. Proteines humaines ctla-8 et utilisation de proteines apparentees aux proteines ctla-8

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 12 January 1996 (1996-01-12), XP002209891, Database accession no. N31809 *
DATABASE EMBL [online] 12 January 1996 (1996-01-12), XP002209892, Database accession no. N31410 *
DATABASE EMBL [online] 15 March 1996 (1996-03-15), XP002209890, Database accession no. N67726 *
JACOBS K ET AL: "A NOVEL METHOD FOR ISOLATING EUKARYOTIC CDNA CLONES ENCODING SECRETED PROTEINS", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, WILEY-LISS, US, VOL. 21A, PAGE(S) 19, ISSN: 0730-2312, XP002027246 *

Also Published As

Publication number Publication date
CA2291260A1 (fr) 1998-12-10
EP1039801A1 (fr) 2000-10-04
WO1998054963A2 (fr) 1998-12-10

Similar Documents

Publication Publication Date Title
EP1039801A4 (fr) 207 proteines humaines secretees
EP1000084A4 (fr) 123 proteines humaines secretees
EP1088071A4 (fr) 94 proteines humaines secretees
EP1100869A4 (fr) 98 proteines humaines secretees
EP1040117A4 (fr) 110 proteines secretees humaines
AU6552198A (en) 28 human secreted proteins
EP1109821A4 (fr) 49 proteines humaines secretees
EP1078046A4 (fr) 97 proteines humaines secretees
EP1140970A4 (fr) 47 proteines humaines secretees
AU6952998A (en) 20 human secreted proteins
EP1051426A4 (fr) 67 proteines humaines secretees
EP1064297A4 (fr) 95 proteines humaines secretees
EP1019091A4 (fr) 50 proteines secretees d'origine humaine
EP1005544A4 (fr) 70 proteines secretees humaines
AU8066998A (en) 86 human secreted proteins
EP1044211A4 (fr) 36 proteines humaines secretees
EP1097199A4 (fr) 71 proteines humaines secretees
EP1115735A4 (fr) 31 proteines humaines secretees
EP1124850A4 (fr) 12 proteines humaines secretees
EP1032838A4 (fr) 125 proteines secretees humaines
EP1027430A4 (fr) Serie de 64 proteines humaines secretees
EP1009766A4 (fr) 19 proteines secretees humaines
EP1062236A4 (fr) 31 proteines humaines secretees
EP1002132A4 (fr) 90 proteines secretees humaines
EP1042674A4 (fr) 148 proteines humaines secretees

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030207

17Q First examination report despatched

Effective date: 20030721

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040201

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CARTER, KENNETH

Inventor name: ENDRESS, GREGORY

Inventor name: DILLON, PATRICK

Inventor name: FENG, PING

Inventor name: YU, GUO-LIANG

Inventor name: KYAW, HLA

Inventor name: ZENG, ZIZHEN

Inventor name: LI, YI

Inventor name: SOPPET, DANIEL

Inventor name: FISCHER, CARRIE

Inventor name: WEI, YING-FEI

Inventor name: FAN, PING

Inventor name: NI, JIAN

Inventor name: LAFLEUR, DAVID

Inventor name: FLORENCE, KIMBERLY

Inventor name: FLORENCE, CHARLES

Inventor name: SHI, YANGGU E

Inventor name: MOORE, PAUL, A.

Inventor name: BREWER, LAURIE, A.

Inventor name: EBNER, REINHARD

Inventor name: OLSEN, HENRIK

Inventor name: HU, JING-SHAN

Inventor name: ROSEN, CRAIG

Inventor name: RUBEN, STEVEN

Inventor name: FERRIE, ANN, M.

Inventor name: GREENE, JOHN

Inventor name: YOUNG, PAUL